FDA Inspection 1109650 — Validus Pharmaceuticals, Inc.

Validus Pharmaceuticals, Inc. — FEI 3006217317

The FDA completed an inspection of Validus Pharmaceuticals, Inc. on Nov 13, 2019 in Parsippany, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 13, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683021 CFR 314.80(c)(2)Interval
683521 CFR 314.80(d)Failure to submit scientific article
891221 CFR 314.81(b)(2)Timely submission

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.